— Know what they know.
Not Investment Advice

063160.KS KSC

CKD Bio Corp.
1W: -0.2% 1M: -9.3% 3M: -5.9% YTD: -40.2% 1Y: -44.6% 3Y: -45.4% 5Y: -78.2%
₩12,790.00 ($9.52)
+10.00 (+0.08%)
 
Weekly Expected Move ±2.3%
₩12211 ₩12501 ₩12790 ₩13079 ₩13369
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 32 · ₩70.2B mcap · 3M float · 1.09% daily turnover

📊 Key Metrics

TTM
₩158B
Revenue
-0.6% YoY
₩-10,743M
Net Income
-670.0% YoY
₩-9,743M
Free Cash Flow
-381.7% YoY
1.8%
Gross Margin
-12.2%
Op. Margin
-13.2%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-8.6%
ROA-3.7%
ROIC-2.4%

Valuation

P/E-6.5
P/B0.6
EV/EBITDA25.7

Leverage

Debt/Equity1.24
Current Ratio1.06
Interest Cov.-1.3x

Quality Scores

Piotroski F3/9
Altman Z1.09
Beneish M3.32

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms